Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia

Metabolism: Clinical and Experimental

Volumn 47, Issue 9, 1998, Pages 1160-1166

  Schmidt, Hartmut H J ^a   Gregg, Richard E ^b   Tietge, Uwe J F ^b   Beisiegel, Ulrike ^b   Zech, Loren A ^b   Brewer Jr , H Bryan ^b   Manns, Michael P ^b   Bojanovski, Dubo ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; ISOTOPE LABELING; LIPOPROTEIN BLOOD LEVEL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METABOLISM; VERTICAL TRANSMISSION; XANTHOMA;

EID: 0031723209     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90294-3     Document Type: Article

References (50)

1. MRFIT Research Group: Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Prev Med 15:254-273, 1986
2. Slack J, Evans KA: The increased risk of death from ischemic heart disease in first degree relatives of 121 men and 96 women with ischemic heart disease. J Med Genet 3:239-242, 1966
3. Kannel WB, Castelli WP, Gordon T, et al: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham Study. Ann Intern Med 74:1-12, 1971
4. Simons LA, Dwyer T, Simons J: Chylomicrons and chylomicron remnants in coronary artery disease: A case control study. Atherosclerosis 65:181-189, 1987
5. Kostner GM, Avogaro P, Cazzolato G, et al: Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38:51-61. 1981
6. Goldstein JL, Brown MS: The low density lipoprotein pathway and its relation to atherosclerosis. Ann Rev Biochem 46:897-930, 1977
7. Goldstein JL, Brown MS: Lipoprotein receptors: Genetic defense against atherosclerosis. Clin Res 30:417-426, 1982
8. Goldstein JL, Brown MS: Familial hypercholesterolemia: A genetic regulatory defect in cholesterol metabolism. Am J Med 58:147-150, 1975
9. Innerarity TL, Mahley RW, Weisgraber KH, et al: Familial defective apolipoprotein B-100: A mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res 31:1337-1349, 1990
10. Pullinger CR, Hennessy LK, Chatterton JE, et al: Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL-receptor binding affinity. J Clin Invest 95:1225-1234, 1995
11. Miller GJ, Miller NE: Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1:16-20, 1975
12. Castelli WP, Doyle JT, Gordon T, et al: HDL cholesterol and other lipids in coronary heart disease. The Cooperative Lipoprotein Phenotyping Study. Circulation 55:767-772, 1977
13. Gordon T, Castelli WP, Hjortland M, et al: High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62:707-714, 1977
14. Schmidt SB, Wassermann AG, Muesing RA, et al: Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol 55:1459-1462, 1985
15. Steinberg D: The rediscovery of high density lipoprotein, a negative risk factor in atherosclerosis. Eur J Clin Invest 8:107-108, 1978
16. Schmidt HH-J, Manns MP: Der reverse Cholesterin Transport. Z Gastroenterol 34:386-391, 1996
17. Avogaro P, Cazzolato G: Familial hyper-HDL-(alpha)-cholesterolemia. Atherosclerosis 22:63-77, 1975
18. Glueck CJ, Fallat RW, Millet F, et al: Familial hyperalphalipoproteinemia. Arch Intern Med 135:1025-1028, 1975
19. Glueck CJ, Kelly K, Mellies MJ, et al: Hypercholesterolemia and hyperalphalipoproteinemia in school children. Pediatrics 62:478-487, 1978
20. Siervogel RM, Morrison JA, Kelly K, et al: Familial hyperalphalipoproteinemia in 26 kindreds. Clin Genet 17:13-25, 1980
21. Avogaro PG, Cazzolato G, Kostner G: Familial hyperalphalipoproteinemia, further studies on serum lipoproteins and some serum enzymes. Clin Chim Acta 77:139-145, 1977
22. Glueck CJ, Gartside P, Fallat RW, et al: Longevity syndromes: Familial hypobeta- and familial hyperalphalipoproteinemia. J Lab Clin Med 88:941-957, 1976
23. Weitzman JB, Vladutiu AO: Very high values of serum highdensity lipoprotein cholesterol. Arch Pathol Lab Med 116:831-836, 1992
24. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34:1345-1353, 1955
25. Brewer HB Jr, Fairwell T, Larue A, et al: The amino acid sequence of human apoA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun 80:623-630, 1978
26. Shapiro AL, Vinuela E, Maizel JV: Molecular weight estimation of polypeptide chains by electrophoresis in SDS-Polyacrylamide Gels. Biochem Biophys Res Commun 28:815-820, 1967
27. Weber K, Osborn M: The reliability of molecular weight determination by dodecyl sulfate polyacrylamide gel electrophoresis. J Biol Chem 244:4406-4412, 1969
28. Mac Farlane AS: Efficient trace-labeling of proteins with iodine. Nature 182:53, 1958
29. Bilheimer DW, Eisenberg S, Levy RI: The metabolism of VLDL. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 260:212-221, 1978
30. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol (proposed selected method). Clin Chem 28:1379-1388, 1982
31. Manual of Laboratory Operations. Lipid Research Clinics Program: Lipid and Lipoprotein Analysis. Washington, DC, Government Printing Office, DHEW NIH publication, 1974, pp 75-628
32. Schaefer EJ, Heaton WH, Wetzel MG, et al: Plasma apolipoprotein A-I absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 2:16-26, 1982
33. Schaefer EJ, Zech LA, Jenkins LL, et al: Human apolipoprotein A-I and A-II metabolism. J Lipid Res 23:850-862, 1982
34. Marcel YI, McPherson R, Hogue M, et al: Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest 85:10-17, 1990
35. Berman M, Weiss M: SAAM Manual. Bethesda, MD, US Department of Health, Education, and Welfare Publication, National Institutes of Health, DHEW Publication no. (NIH) 78, 1978, pp 75-180
36. Schuster H, Rauh G, Kormann B, et al: Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich. Arteriosclerosis 10:577-581, 1990
37. Hansen PS, Rüdiger N, Tybjaerg-Hansen A: Detection of the apoB 3500 mutation (glutamine for arginine) by gene amplification and cleavage with Msp I. J Lipid Res 32:1229-1233, 1991
38. Goldstein JL, Brown MS: Binding and degradation of low density lipoproteins by cultured human fibroblasts. J Biol Chem 249:5153-5162, 1974
39. Goldstein JL, Brown MS: The LDL receptor locus and the genetics of familial hypercholesterolemia. Ann Rev Genet 13:259-289, 1979
40. Naito HK, Lewis LA, McCormack LJ: Hyperalphalipoproteinemia: A case study. Clin Chem 21:639-641, 1975
41. Mendoza S, Lutmer RF, Glueck CJ: Composition of HDL-2 and HDL-3 in familial hyperalphalipoproteinemia. Atherosclerosis 25:131-136, 1976
42. Yamashita S, Matsuzawa Y, Okazaki M, et al: Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis 70:7-12, 1988
43. Barter PJ, Lally JI: The activity of an esterified cholesterol transferring factor in human serum. Biochim Biophys Acta 531:233-236, 1978
44. Taskinen MR, Nikkilä EA: High-density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man - Evidence for reciprocal regulation of HDL-2 and HDL-3 levels by lipoprotein lipase. Clin Chim Acta 112:325-332, 1981
45. Brousseau ME, Santamarina-Fojo S, Zech LA, et al: Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J Clin Invest 97:1844-1851, 1996
46. Connelly PW, Maguire GF, Lee M, et al: Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10:40-48, 1990
47. Kuusi T, Ehnholm C, Viikari J, et al: Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia. J Lipid Res 30:1117-1126, 1989
48. Rader DJ, Schaefer JR, Lohse P, et al: Increased production of apolipoprotein A-I associated with elevated plasma levels of highdensity lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia. Metabolism 42:1429-1434, 1993
49. Monge JC, Hoeg JM, Law SW, et al: Low density lipoproteins induce coordinate regulation of human apolipoprotein A-I and B-100 biosynthesis in HepG2 cells. Clin Res 34:443A, 1986 (abstr)
50. Monge JC, Hoeg JM, Law SW, et al: Effect of low density lipoproteins, high density lipoproteins, and cholesterol on apolipoprotein A-I mRNA in HepG2 cells. FEBS Lett 243:213-217, 1989